Episode 286 - Researching IPMNs & Early Detection with Dr. Elishama Kanu of Duke University

Meet Dr. Elishama Kanu, a general surgery resident at the Duke University School of Medicine Pancreatic Cancer Research Laboratory. She was recently awarded the Project Purple Innovations Grant for $100,000 to advance genomic profiling of IPMNs and correlate the information with clinical patient samples for the detection of biomarkers signaling high risk for malignant degeneration.

In this episode of the Project Purple Podcast, Dr. Kanu describes her role at Duke and shares in-depth explanations about the goal of her research. She emphasizes the importance of early detection in pancreatic cancer patients. She touches on the ways she and her research aim to pinpoint those who may be at high risk of developing pancreatic cancer later in life.

Dr. Kanu also discusses research methods, including her work in immunotherapies. She speaks about her passion for research, how she became a resident at the Duke University School of Medicine, and her unique opportunity to gain clinical and research experience under Dr. Peter Allen and others.

Join us for this very informative and optimistic episode of the Project Purple Podcast!

If you’d like to donate to Project Purple’s mission of a world without pancreatic cancer, please visit https://www.projectpurple.org/.

To learn more about Duke University’s pancreatic cancer research efforts, visit their website at: www.dukepcrl.com

To learn more about Project Purple, visit https://www.projectpurple.org/ or follow us on social media at these links: https://www.facebook.com/Run4ProjectPurple
https://www.instagram.com/projectpurple/
https://twitter.com/Run4Purple
https://www.youtube.com/channel/UCgA8nVhUY6_MLj5z3rnDQZQ